Cullinan Oncology, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.67 |
6.50 |
30.13 |
43.64 |
22.36 |
135.79 |
| Przychód Δ r/r |
0.00% |
290.00% |
363.53% |
44.85% |
-48.77% |
507.39% |
| Przychód (min) |
1.10 |
4.28 |
29.29 |
43.64 |
14.73 |
89.49 |
| Przychód (max) |
2.24 |
8.72 |
30.97 |
43.64 |
29.99 |
182.14 |
| EBITDA (średnia) |
1.00 |
3.90 |
18.08 |
26.18 |
13.41 |
81.48 |
| EBIT (średnia) |
1.00 |
3.90 |
18.08 |
26.18 |
13.41 |
81.48 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-166.14 |
-171.23 |
-158.23 |
-148.87 |
-176.37 |
-145.18 |
| Zysk netto % |
-9968.27% |
-2634.37% |
-525.18% |
-341.12% |
-788.88% |
-106.91% |
| EPS (średnia) |
-2.99 |
-3.18 |
-3.00 |
-2.76 |
-3.28 |
-2.70 |
| Liczba analityków (Przychody) |
5 |
6 |
9 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
8 |
6 |
7 |
6 |
3 |
4 |
| symbol |
CGEM |
CGEM |
CGEM |
CGEM |
CGEM |
CGEM |